Centers for Disease Control and Prevention of US Department of Health and Human Services awarded US$11.4 M to four companies, Cepheid, IQuum, Meso Scale Diagnostics and Nanogen to develop diagnostic tests for avian influenza A H5N1 and other emerging flu viruses.